EvoNext Holdings SA (ELVAF)
OTCMKTS · Delayed Price · Currency is USD
1.100
-0.050 (-4.35%)
At close: Oct 10, 2025
EvoNext Holdings Market Cap
EvoNext Holdings has a market cap or net worth of $7.48 million as of October 17, 2025. Its market cap has decreased by -0.95% in one year.
Market Cap
7.48M
Enterprise Value
-486.05K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.10
Market Cap Chart
Since March 1, 2010, EvoNext Holdings's market cap has decreased from 361.87M to 7.48M, a decrease of -97.93%. That is a compound annual growth rate of -21.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 7.48M | 4.56% |
| Dec 30, 2024 | 7.16M | 22.89% |
| Dec 29, 2023 | 5.82M | -94.09% |
| Dec 30, 2022 | 98.47M | -29.13% |
| Dec 30, 2021 | 138.93M | -21.94% |
| Dec 30, 2020 | 177.97M | 1.68% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |